Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Higher platelet doses in PRP therapy improve outcomes for musculoskeletal issues.

High-dose oral minoxidil in children can cause increased hair growth, especially on the face.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

A woman's hair loss led to discovering she had lupus.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Noninvasive scalp imaging techniques can improve patient care by reducing the need for biopsies.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

Review finds no permanent solution for female hair loss.

Buffy coat PRP is more effective for hair growth in androgenetic alopecia than apheresis PRP.

The buffy coat method slightly outperformed apheresis in patient-reported hair improvement for treating hair loss.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Severe acne patients have higher inflammatory markers than healthy people.

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Teledermatology is highly effective for diagnosing and managing hair loss.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.